---
figid: PMC4653019__oncotarget-06-20474-g006
figlink: /pmc/articles/PMC4653019/figure/F6/
number: F6
caption: . A diagram describes the mechanisms by which catalytic Topo II inhibitors
  and anti-AR agents block AR pathway in prostate cancer cells.
pmcid: PMC4653019
papertitle: Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor
  signaling and prostate cancer progression.
reftext: Haolong Li, et al. Oncotarget. 2015 Aug 21;6(24):20474-20484.
pmc_ranked_result_index: '14656'
pathway_score: 0.9676284
filename: oncotarget-06-20474-g006.jpg
figtitle: Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor
  signaling and prostate cancer progression
year: '2015'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4653019__oncotarget-06-20474-g006.html
  '@type': Dataset
  description: . A diagram describes the mechanisms by which catalytic Topo II inhibitors
    and anti-AR agents block AR pathway in prostate cancer cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AR
  - Abiraterone
  - Enzalutamide
  - Androgen
genes:
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
chemicals:
- word: Abiraterone
  source: MESH
  identifier: C089740
- word: Enzalutamide
  source: MESH
  identifier: C540278
- word: Androgen
  source: MESH
  identifier: D000728
diseases: []
figid_alias: PMC4653019__F6
redirect_from: /figures/PMC4653019__F6
figtype: Figure
---
